KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Gross Margin (2017 - 2025)

Cardlytics (CDLX) has disclosed Gross Margin for 9 consecutive years, with 86.59% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin rose 192.0% year-over-year to 86.59%, compared with a TTM value of 83.08% through Dec 2025, up 199.0%, and an annual FY2025 reading of 83.08%, up 199.0% over the prior year.
  • Gross Margin was 86.59% for Q4 2025 at Cardlytics, up from 84.88% in the prior quarter.
  • Across five years, Gross Margin topped out at 86.59% in Q4 2025 and bottomed at 70.85% in Q2 2022.
  • Average Gross Margin over 5 years is 79.02%, with a median of 79.5% recorded in 2022.
  • The sharpest move saw Gross Margin plummeted -246bps in 2021, then soared 933bps in 2023.
  • Year by year, Gross Margin stood at 78.9% in 2021, then grew by 1bps to 79.61% in 2022, then increased by 6bps to 84.17% in 2023, then increased by 1bps to 84.67% in 2024, then rose by 2bps to 86.59% in 2025.
  • Business Quant data shows Gross Margin for CDLX at 86.59% in Q4 2025, 84.88% in Q3 2025, and 82.08% in Q2 2025.